Chronic THC treatment for 14 days made rats hypersensitive to the psychomotor effects of amphetamine after withdrawal, supporting the hypothesis that cannabis use could increase vulnerability to stimulant-induced psychosis.
Read this if you want to understand the neuroscience behind the proposed link between cannabis use and psychosis risk.
THC withdrawal sensitized rats to amphetamine's psychosis-like effects
What the researchers found
Researchers investigated whether chronic cannabis exposure could sensitize the brain to psychosis-like effects, using amphetamine-induced behavior in rats as a model.
Three patterns emerged across different exposure conditions. Acute THC antagonized amphetamine's stimulant effects, essentially blocking the amphetamine response. During chronic THC treatment (14 days), tolerance developed to this blocking effect on some measures, while amphetamine-induced stereotypies (repetitive behaviors) were actually potentiated.
Most significantly, 24 hours after stopping 14 days of THC, rats showed sensitization to amphetamine's effects. The animals became hyperresponsive to amphetamine's ability to increase locomotion, exploration, and stereotypies. This sensitization pattern parallels what is seen in animal models of psychosis.
Since CB1 receptors are densely located in limbic and basal ganglia circuits where amphetamine enhances dopamine and serotonin, these findings supported a role for the cannabinoid system in regulating the monoaminergic circuits implicated in psychosis.
Why it matters
This study provided a mechanistic model for how cannabis use might increase vulnerability to psychosis. By demonstrating that chronic THC exposure sensitizes the dopamine system, it connected two previously separate observations: clinical reports of cannabis-associated psychosis and the dopamine hypothesis of schizophrenia.
The numbers in context
Two THC doses: 0.1 and 6.4 mg/kg. Fourteen days of chronic treatment. Sensitization observed 24 hours after last dose. Three behavioral measures showing sensitization: locomotion, exploration, stereotypies.
How the study worked
Animal behavioral pharmacology in male rats. Three conditions: acute THC, chronic THC (14 days), and 24-hour withdrawal after chronic THC. Two doses of THC (0.1 and 6.4 mg/kg). Amphetamine responses measured on a hole-board assessing locomotion, exploration, inactivity, and stereotypies.
What this study cannot tell us
Animal model using forced drug administration, not voluntary use. The amphetamine-psychosis model is an approximation of human psychosis, not a direct equivalent. The 24-hour withdrawal timepoint may represent an acute withdrawal state rather than lasting sensitization.
How to read the evidence
An animal behavioral pharmacology study with clear dose-response and temporal patterns. Provides mechanistic insight but limited by animal-to-human translation.
When this study was published
Published in 1999. The cannabis-psychosis connection has been extensively studied since, with both epidemiological and neuroimaging data supporting a dose-dependent risk.
The bigger picture
Cross-sensitization between cannabis and dopaminergic drugs became an important line of evidence in the cannabis-psychosis literature. This animal model suggested a biological mechanism by which cannabis might not directly cause psychosis but could lower the threshold for psychosis triggered by other factors.
Questions still open
- Does this sensitization persist beyond 24 hours? Would it occur with intermittent rather than daily dosing? Can this animal model predict which human cannabis users are at risk for psychosis?
Common questions
Does this mean cannabis causes psychosis?
What does sensitization mean?
Read the original research
Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats.
European journal of pharmacology, 365(2-3), 133-42
Citation
Gorriti, M A; Rodríguez de Fonseca, F; Navarro, M; Palomo, T. (1999). Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats.. European journal of pharmacology, 365(2-3), 133-42.
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)
- Why Does Weed Make You Laugh? THC and Humor Processing
- THC and Adderall: Stimulants and Cannabis in the Same Brain
- THC and Antipsychotics: A Complicated Relationship